MedPath

Risk of Airborne Particulate matter: a Toxicological and Epidemiological hybrid Study

Completed
Conditions
respiratory tract inflammation
thrombogenesis
10018849
10082206
10006436
Registration Number
NL-OMON32662
Lead Sponsor
niversiteit Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

healthy, non smoking, 18-35 years of age, living in students housing facilities at the campus of Utrecht University (de Uithof), good understanding of the Dutch language

Exclusion Criteria

lifetime diagnosis asthma or COPD
recent wheeze, shortness of breath, chronic cough
history of high blood pressure, angina pectoris or myocardial infarction
medication for respiratory or cardiovascular disease
diabetes mellitus
obesity
smoking or living in a household with a smoker
pregnancy

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Respiratory and cardiovascular health will be assessed before and after the<br /><br>exposure. These will include recording of symptoms, spirometry (peakflow, FEV1,<br /><br>FVC, FEF25-75), nasal lavage, exhaled NO and CO, blood pressure, oxygen<br /><br>saturation in blood, heart rate, and blood sampling. Plasma samples and nasal<br /><br>lavage will be analyzed on inflammation markers.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>We will administer a time activity questionnaire to assess exposure to indoor<br /><br>sources (e.g. smoking, cooking), participation in traffic, and time spent<br /><br>outdoors. These measurements will be used to document the relative contribution<br /><br>of pre- and post experiment exposures, compared to exposure during the<br /><br>experiment.</p><br>
© Copyright 2025. All Rights Reserved by MedPath